Kiji Tx was present last Sunday at the #NYMarathon through our CSO Anthony Ting. The race was not easy, but following the same philosophy that we have in Kiji, Tony overcame the obstacles and achieved his goal, to reach the finish line. We are very proud of you Tony! Congratulations!
Kiji Therapeutics
Recherche en biotechnologie
Paris, Île-de-France 386 abonnés
Gene engineered cell therapies for life-threatening disease
À propos
Kiji Therapeutic, Incorporated in France and Spain in 2023, develops transformative off-the-shelf engineered cell therapies for life-threatening diseases. Kiji-TX has a platform to gene engineer iPSC derived MSC cells for a targeted and optimized therapeutic benefit. The first asset is engineered with IL10/CXCR4 and targets several autoimmune diseases.
- Site web
-
www.kiji-tx.com
Lien externe pour Kiji Therapeutics
- Secteur
- Recherche en biotechnologie
- Taille de l’entreprise
- 2-10 employés
- Siège social
- Paris, Île-de-France
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2023
Lieux
-
Principal
Obtenir l’itinéraire
4, Rue Thénard
75005 Paris, Île-de-France, FR
Employés chez Kiji Therapeutics
Nouvelles
-
Kiji Therapeutics a republié ceci
Erin Harris, editor, Cell & Gene, a Life Science Connect publication, has issued her main podcast recorded live from Meeting on the Mesa with the most important person currently in #CGT, Dr. Miguel Forte, President, ISCT, International Society for Cell & Gene Therapy, Alliance for Regenerative Medicine board memer, and CEO of Kiji Therapeutics. They discuss Kiji's #clinical plan and why #iPSC-#MSC #therapy for #inflammatory diseases shows great promise. They also cover this year's conference and what to expect during and after the event. https://lnkd.in/eKKg8c9f
-
-
Don't miss episode 88 of Cell & Gene podcast in which our CEO Miguel Forte talks about Kiji's clinical plan and platform for the treatment of inflammatory diseases #celltherapy #inflammatoydiseases #MSCs #iPSCs
Episode 88 of Cell & Gene: The Podcast is available! 🎙️ Recorded on site at the Alliance for Regenerative Medicine 2024 Meeting on the Mesa in Phoenix, this episode features an insightful conversation with Miguel Forte, M.D., Ph.D., CEO of Kiji Therapeutics. Tune in to learn about Kiji's clinical plan and the promising #iPSC-MSC therapy for inflammatory diseases. Plus, get a sneak peek into this year's conference highlights and post-event insights. Don't miss out on this engaging discussion. Subscribe now wherever you podcast. https://lnkd.in/eKV-65bu #cellandgenetherapy #cgt #regenerativemedicine #inflammatorydisease #podcast #CGMesa24 ISCT, International Society for Cell & Gene Therapy
-
We are pleased to announce that we intend to merge with REGiMMUNE Corporation. The creation of the merged company will combine three different platforms based on small molecules, monoclonal antibodies and cell and gene therapy to create an international Treg biotech and the world leader in Treg function modulation. The combination of these technologies will create an international specialist in Treg modulation with a focus on immuno-oncology and autoimmunity. #Kijitherapeutics #Regimmune #Tregs #cellandgenetherapy #Biotech #monoclonalantibodies #smallmolecules #autoimmunity #immunooncology
-
Great JPM week to all! On the way to San Francisco for the always exciting, energizing and sometimes frustrating JPM. Great expectations and potential. Looking forward to the planned meetings and the multiple "bumped into you" opportunities! Kiji Therapeutics will be presented at 9:30 am PT on Wednesday the 10th. Do come along or reach out for a connection or a chat! Safe travels and hope to see you at JPM this week! Miguel Forte
-